Cardiologie 2020

In the past 2 decades the 1-year risk of mortality from an acute coronary syndrome has decreased from 22% to 11%, mainly thanks to better antiplatelet treatment, earlier revascularisation and lower LDL cholesterol target values. Direct anticoagulants, PCSK9 inhibitors and new drugs for patients with heart failure have further improved the prognosis for cardiovascular diseases. In patients with aortic valve stenosis, transcatheter aortic valve implantations are now more frequently performed than surgical aortic valve replacements. Treatment of coronary disease with bioabsorbant stents and regeneration of necrotic heart muscle tissue with stem cell injection have yet been unsuccessful. In the coming decade, advances in gene therapy, genetic risk prediction, imaging techniques, artificial intelligence and home-monitoring will allow further tailoring of cardiological care to the individual patient.

Conflict of interest and financial support: none declared.